Dr. Philip Efron, a distinguished professor of surgery at the University of Florida, recently presented his groundbreaking research titled “TRANSCRIPTOME‐GUIDED PRECISION THERAPY FOR SURGICAL SEPSIS” at the 136th Annual Meeting of the Southern Surgical Association. His work focuses on leveraging transcriptomic data to develop precision therapies tailored for patients suffering from surgical sepsis, a critical condition characterized by the body’s extreme response to infection following surgery. By utilizing advanced genomic techniques, Dr. Efron’s research aims to improve patient outcomes through more personalized and effective treatment strategies. This innovative approach highlights the potential of precision medicine in transforming the management of sepsis and underscores Dr. Efron’s commitment to advancing surgical care.